These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23002965)

  • 21. Universal influenza vaccines: a realistic option?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the safety of influenza vaccination in specific populations: children and the elderly.
    Rowhani-Rahbar A; Klein NP; Baxter R
    Expert Rev Vaccines; 2012 Aug; 11(8):973-84. PubMed ID: 23002978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Learning from the 2009 H1N1 pandemic: prospects for more broadly effective influenza vaccines.
    Settembre EC; Dormitzer PR; Rappuoli R
    J Mol Cell Biol; 2011 Jun; 3(3):144-6. PubMed ID: 21430014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Antibodies Against Influenza Proteins.
    Padilla-Quirarte HO; Lopez-Guerrero DV; Gutierrez-Xicotencatl L; Esquivel-Guadarrama F
    Front Immunol; 2019; 10():1677. PubMed ID: 31379866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A; Janulíková J; Varecková E
    Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WHO announces flu vaccine formula for 1998-1999.
    Public Health Rep; 1998; 113(3):193. PubMed ID: 9633856
    [No Abstract]   [Full Text] [Related]  

  • 28. Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency.
    Wagner R; Pfleiderer M
    Expert Rev Vaccines; 2012 Aug; 11(8):881-3. PubMed ID: 23002967
    [No Abstract]   [Full Text] [Related]  

  • 29. Influenza virus split vaccines. Effect of priming infection on serologic response in humans.
    Niculescu IT; Zilisteanu E; Cretescu L; Matepiuc M; Dumitrescu R; Oprescu E; Bodnar C; Cuteanu I; Vlad A; Mogos A
    Arch Roum Pathol Exp Microbiol; 1979; 38(2):147-54. PubMed ID: 262510
    [No Abstract]   [Full Text] [Related]  

  • 30. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immune responses to recurring influenza strains have limited boosting ability and limited cross-reactivity to other strains.
    Keynan Y; Card CM; Ball BT; Li Y; Plummer FA; Fowke KR
    Clin Microbiol Infect; 2010 Aug; 16(8):1179-86. PubMed ID: 20670292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avian influenza. 'Pandemic vaccine' appears to protect only at high doses.
    Enserink M
    Science; 2005 Aug; 309(5737):996. PubMed ID: 16099954
    [No Abstract]   [Full Text] [Related]  

  • 33. Intranasal influenzavirus vaccine in children.
    Edwards KM; Dupont WD
    N Engl J Med; 1998 Sep; 339(13):922; author reply 922-3. PubMed ID: 9750091
    [No Abstract]   [Full Text] [Related]  

  • 34. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 37. Interferon-β modulates type 1 immunity during influenza virus infection.
    Yoo JK; Baker DP; Fish EN
    Antiviral Res; 2010 Oct; 88(1):64-71. PubMed ID: 20659503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The systemic and mucosal immune response of humans to influenza A virus.
    Murphy BR; Clements ML
    Curr Top Microbiol Immunol; 1989; 146():107-16. PubMed ID: 2659262
    [No Abstract]   [Full Text] [Related]  

  • 39. Preflucel®: a Vero-cell culture-derived trivalent influenza vaccine.
    Chan CY; Tambyah PA
    Expert Rev Vaccines; 2012 Jul; 11(7):759-73. PubMed ID: 22913252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.